Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duane A Mitchell

Showing results (111-120 of 129) with videos related to

Pageof 13
Sort By:
Blood|July 20, 2011
Monoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humansDuane A Mitchell, Xiuyu Cui, Robert J Schmittling, et al.
Neuro-Oncology|December 15, 2010
Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastomaJohn H Sampson, Kenneth D Aldape, Gary E Archer, et al.
Nature Communications|July 12, 2024
Adeno-associated virus delivered CXCL9 sensitizes glioblastoma to anti-PD-1 immune checkpoint blockadeChristina A von Roemeling, Jeet A Patel, Savannah L Carpenter, et al.
Nature Cancer|February 5, 2022
The current landscape of immunotherapy for pediatric brain tumorsEugene I Hwang, Elias J Sayour, Catherine T Flores, et al.
Acta Biomaterialia|October 3, 2023
Bioconjugated liquid-like solid enhances characterization of solid tumor - chimeric antigen receptor T cell interactionsDuy T Nguyen, Ruixuan Liu, Elizabeth Ogando-Rivas, et al.
Nature Communications|September 7, 2019
CXCR1- or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumorsLinchun Jin, Haipeng Tao, Aida Karachi, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2023
Three-Dimensional Bioconjugated Liquid-Like Solid (LLS) Enhance Characterization of Solid Tumor - Chimeric Antigen Receptor T cell interactionsDuy T Nguyen, Ruixuan Liu, Elizabeth Ogando-Rivas, et al.
Nature|March 13, 2015
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patientsDuane A Mitchell, Kristen A Batich, Michael D Gunn, et al.
Oncoimmunology|July 30, 2016
Prioritization schema for immunotherapy clinical trials in glioblastomaTiffany R Hodges, Sherise D Ferguson, Hillary G Caruso, et al.
The EMBO Journal|October 17, 2018
Infiltrative and drug-resistant slow-cycling cells support metabolic heterogeneity in glioblastomaLan B Hoang-Minh, Florian A Siebzehnrubl, Changlin Yang, et al.
Pageof 13

Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
Blood|July 20, 2011
Monoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humansDuane A Mitchell, Xiuyu Cui, Robert J Schmittling, et al.
Neuro-Oncology|December 15, 2010
Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastomaJohn H Sampson, Kenneth D Aldape, Gary E Archer, et al.
Nature Communications|July 12, 2024
Adeno-associated virus delivered CXCL9 sensitizes glioblastoma to anti-PD-1 immune checkpoint blockadeChristina A von Roemeling, Jeet A Patel, Savannah L Carpenter, et al.
Nature Cancer|February 5, 2022
The current landscape of immunotherapy for pediatric brain tumorsEugene I Hwang, Elias J Sayour, Catherine T Flores, et al.
Acta Biomaterialia|October 3, 2023
Bioconjugated liquid-like solid enhances characterization of solid tumor - chimeric antigen receptor T cell interactionsDuy T Nguyen, Ruixuan Liu, Elizabeth Ogando-Rivas, et al.
Nature Communications|September 7, 2019
CXCR1- or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumorsLinchun Jin, Haipeng Tao, Aida Karachi, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2023
Three-Dimensional Bioconjugated Liquid-Like Solid (LLS) Enhance Characterization of Solid Tumor - Chimeric Antigen Receptor T cell interactionsDuy T Nguyen, Ruixuan Liu, Elizabeth Ogando-Rivas, et al.
Nature|March 13, 2015
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patientsDuane A Mitchell, Kristen A Batich, Michael D Gunn, et al.
Oncoimmunology|July 30, 2016
Prioritization schema for immunotherapy clinical trials in glioblastomaTiffany R Hodges, Sherise D Ferguson, Hillary G Caruso, et al.
The EMBO Journal|October 17, 2018
Infiltrative and drug-resistant slow-cycling cells support metabolic heterogeneity in glioblastomaLan B Hoang-Minh, Florian A Siebzehnrubl, Changlin Yang, et al.
Pageof 13